QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 00:27 UTC · Public disclosure record

DOCTICKER

Healthpeak Properties, Inc.

BULLISH stock

Congress has disclosed 5 buys and 7 sells of DOC (Healthpeak Properties, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

5
Buy
7
Sell
-2
Net
7
Active politicians

Round-trip watch Still on the books

Members who disclosed buying DOC and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Alan Armstrong 2026-03-27 $16.00 $19.03 +18.9% in profit

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Finance. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
34.75
▲ pricier than Finance (median 17.2)
how it's calculated
P/E = price ÷ earnings per share
$19.03 ÷ $0.55 = 34.75
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
1.67
≈ in line with Finance (median 1.8)
how it's calculated
P/B = price ÷ book value per share
$19.03 ÷ $11.41 = 1.67
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

Legislation Related Legislation

Recent bills in this stock's sector (Finance). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.

BillTitlePolicy areaLatest action
HR 10820 Epstein Wall Street Records Act of 2026 Finance and Financial Sector 2026-10-15
HR 10821 To amend the Federal Deposit Insurance Act to make changes to the Standard Maximum Deposit Insurance Amount, and for other purposes. Finance and Financial Sector 2026-10-15
S 4395 Terrorism Risk Insurance Program Reauthorization Act of 2026 Finance and Financial Sector 2026-10-05
S 1564 Floodplain Enhancement and Recovery Act Finance and Financial Sector 2026-10-05
S 5644 A bill to amend title 31, United States Code, to exempt transactions with respect to cash reward payments by crime stopper organizations from certain currency transaction reports. Finance and Financial Sector 2026-09-30

12 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Alan Armstrong Senate BUY ◆ insider divergence Self 2026-03-27 116 days +39.1% $1K–$15K 82.9 ↗ eFD
Michael McCaul House SELL OCR ◆ insider convergence Spouse 2026-03-23 14 days -2.9% $100K–$250K 69.6 ↗ filing
Gilbert Cisneros House SELL Self · 150 Main Street Trust > Bank of America 2026-02-10 24 days +2.3% $1K–$15K
0.1% of NW
29.1 ↗ filing
Michael McCaul House BUY OCR Spouse 2026-02-06 27 days +4.0% $100K–$250K 97.9 ↗ filing
Gilbert Cisneros House BUY Self · 150 Main Street Trust > Bank of America 2026-01-09 33 days +2.1% $1K–$15K
0.1% of NW
66.9 ↗ filing
Lisa McClain House SELL ◆ insider divergence · strong Spouse · Charles Schwab Brokerage Account 924 2025-08-04 9 days +1.4% $1K–$15K
0.1% of NW
84.7 ↗ filing
Lisa McClain House BUY ◆ insider convergence · strong Spouse · Charles Schwab Brokerage Account 924 2025-06-17 57 days +1.3% $1K–$15K
0.1% of NW
97.4 ↗ filing
Rob Bresnahan House SELL ◆ insider divergence · strong Self · JP Morgan Brokerage Account 2025-05-15 0 days 0.0% $1K–$15K
0.2% of NW
64.5 ↗ filing
Julie Johnson House SELL ◆ insider divergence · strong Joint · Merrill Lynch Tax Efficient Core 2025-04-01 35 days -12.4% $1K–$15K
<0.1% of NW
62.6 ↗ filing
Christopher Jacobs House BUY Self · CL TRUST > LDJ FAM INV LLC > Parametric 2022-12-12 29 days — $1K–$15K 22.3 ↗ filing
Christopher Jacobs House SELL Self · CL TRUST > LDJ FAM INV LLC > Parametric 2022-11-08 29 days — $1K–$15K 40.4 ↗ filing
Christopher Jacobs House SELL Self · CL TRUST > LDJ FAM INV LLC > Parametric 2022-07-18 23 days — $1K–$15K 75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in DOC — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

2
Congress trades with insider convergence
4
…with insider divergence
20
Insider open-market trades

Of the congressional trades in DOC, 2 coincided with corporate insiders moving the same way within 60 days, and 4 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-05-12 Bohn Scott R Other SELL $214K ↗ EDGAR
2025-08-06 Thomas John T Director BUY $25K ↗ EDGAR
2025-08-04 Brinker Scott M C-suite BUY $25K ↗ EDGAR
2025-07-31 Brinker Scott M C-suite BUY $50K ↗ EDGAR
2025-07-28 Brinker Scott M C-suite BUY $50K ↗ EDGAR
2025-05-28 Thompson Tommy G Director BUY $100K ↗ EDGAR
2025-05-09 Brinker Scott M C-suite BUY $48K ↗ EDGAR
2025-05-09 Thompson Tommy G Director BUY $99K ↗ EDGAR
2025-04-29 Lias-Booker Ava Director BUY $89K ↗ EDGAR
2025-04-28 Brinker Scott M C-suite BUY $200K ↗ EDGAR
2025-04-28 SHELLEY-KESSLER PAMELA Director BUY $25K ↗ EDGAR
2025-04-28 SHELLEY-KESSLER PAMELA Director BUY $25K ↗ EDGAR
2025-04-28 Lewis Sara Grootwassink Director BUY $106K ↗ EDGAR
2025-04-28 Sandstrom Katherine M Director BUY $199K ↗ EDGAR
2025-04-28 Thomas John T Director BUY $75K ↗ EDGAR
2024-03-04 Lewis Sara Grootwassink Director BUY $301K ↗ EDGAR
2023-03-15 Lewis Sara Grootwassink Director BUY $86K ↗ EDGAR
2023-03-07 Klaritch Thomas C-suite BUY $35K ↗ EDGAR
2023-03-02 Brinker Scott M C-suite BUY $385K ↗ EDGAR
2023-02-22 GARVEY CHRISTINE Director SELL $31K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-05-12 Bohn Scott R Other SELL $214K
Congress 2026-03-27 Alan Armstrong BUY $1K–$15K
Congress 2026-03-23 Michael McCaul SELL $100K–$250K
Congress 2026-02-10 Gilbert Cisneros SELL $1K–$15K
Congress 2026-02-06 Michael McCaul BUY $100K–$250K
Congress 2026-01-09 Gilbert Cisneros BUY $1K–$15K
◆ insider 2025-08-06 Thomas John T Director BUY $25K
Congress 2025-08-04 Lisa McClain SELL $1K–$15K
◆ insider 2025-08-04 Brinker Scott M C-suite BUY $25K
◆ insider 2025-07-31 Brinker Scott M C-suite BUY $50K
◆ insider 2025-07-28 Brinker Scott M C-suite BUY $50K
Congress 2025-06-17 Lisa McClain BUY $1K–$15K
◆ insider 2025-05-28 Thompson Tommy G Director BUY $100K
Congress 2025-05-15 Rob Bresnahan SELL $1K–$15K
◆ insider 2025-05-09 Brinker Scott M C-suite BUY $48K
◆ insider 2025-05-09 Thompson Tommy G Director BUY $99K
◆ insider 2025-04-29 Lias-Booker Ava Director BUY $89K
◆ insider 2025-04-28 Brinker Scott M C-suite BUY $200K
◆ insider 2025-04-28 SHELLEY-KESSLER PAMELA Director BUY $25K
◆ insider 2025-04-28 SHELLEY-KESSLER PAMELA Director BUY $25K
◆ insider 2025-04-28 Lewis Sara Grootwassink Director BUY $106K
◆ insider 2025-04-28 Sandstrom Katherine M Director BUY $199K
◆ insider 2025-04-28 Thomas John T Director BUY $75K
Congress 2025-04-01 Julie Johnson SELL $1K–$15K

FAQ Common questions

How much has Congress traded DOC?

5 disclosed buys and 7 sells of DOC (Healthpeak Properties, Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade DOC?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.